Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115905964 | 11590596 | 4 | F | 20140923 | 20160826 | 20151002 | 20160912 | PER | US-JNJFOC-20150926366 | JANSSEN | 86.55 | YR | E | M | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115905964 | 11590596 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 115905964 | 11590596 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 115905964 | 11590596 | 3 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 202439 | 20 | MG | TABLET | |||||
| 115905964 | 11590596 | 4 | SS | COUMADIN | WARFARIN SODIUM | 1 | Oral | Y | 0 | 5 | MG | TABLET | QD | ||||||
| 115905964 | 11590596 | 5 | SS | COUMADIN | WARFARIN SODIUM | 1 | Oral | Y | 0 | 5 | MG | TABLET | QD | ||||||
| 115905964 | 11590596 | 6 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
| 115905964 | 11590596 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 115905964 | 11590596 | 8 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 115905964 | 11590596 | 9 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 115905964 | 11590596 | 10 | C | NITROSTAT | NITROGLYCERIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 115905964 | 11590596 | 11 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115905964 | 11590596 | 1 | Pulmonary embolism |
| 115905964 | 11590596 | 2 | Cerebrovascular accident prophylaxis |
| 115905964 | 11590596 | 3 | Atrial fibrillation |
| 115905964 | 11590596 | 4 | Transient ischaemic attack |
| 115905964 | 11590596 | 5 | Atrial fibrillation |
| 115905964 | 11590596 | 6 | Product used for unknown indication |
| 115905964 | 11590596 | 7 | Product used for unknown indication |
| 115905964 | 11590596 | 8 | Product used for unknown indication |
| 115905964 | 11590596 | 9 | Product used for unknown indication |
| 115905964 | 11590596 | 10 | Product used for unknown indication |
| 115905964 | 11590596 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115905964 | 11590596 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115905964 | 11590596 | Cerebral haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115905964 | 11590596 | 1 | 20130801 | 20140923 | 0 | |
| 115905964 | 11590596 | 2 | 20130801 | 20140923 | 0 | |
| 115905964 | 11590596 | 3 | 20130801 | 20140923 | 0 | |
| 115905964 | 11590596 | 4 | 20140204 | 0 | ||
| 115905964 | 11590596 | 5 | 20140204 | 0 |